Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care — Stella

Recruiting

Back to Diabetic Retinopathy trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Brazil

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul

Key details

Sponsor

Hospital de Clinicas de Porto Alegre

Collaborators

Fundação de Amparo à Pesquisa do Estado de São Paulo, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil

Enrollment target

~922 participants

Started

August 2024

Primary completion

August 2026

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov